Table 3 Characteristics of included studies in the meta-analysis analyzing the effect of the CD14 polymorphism on sepsis-related mortality
Study | SNP | Non-survivors (n) | Survivors (n) | Distribution of alleles | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CC | CT | TT | CC | CT | TT | Non-survivors | Survivors | ||||
C | T | C | T | ||||||||
Barber, 2007 [28] | CD14-159C/T | 19 | 18 | 4 | 51 | 95 | 46 | 56 | 26 | 197 | 187 |
Dong, 2010 [35] | CD14-159C/T | 1 | 4 | 4 | 6 | 12 | 8 | 6 | 12 | 24 | 28 |
Gibot, 2002 [22] | CD14-159C/T | 5 | 25 | 20 | 14 | 18 | 8 | 35 | 65 | 46 | 34 |
Hubacek, 2000 [26] | CD14-159C/T | 21 | 59 | 17 | 32 | 52 | 23 | 101 | 93 | 116 | 98 |
Jessen, 2007 [39] | CD14-159C/T | 18 | 33 | 11 | 74 | 123 | 55 | 69 | 55 | 271 | 233 |
Lin, 2004 [32] | CD14-159C/T | 0 | 4 | 3 | 2 | 6 | 1 | 4 | 10 | 10 | 8 |
Shimada, 2011 [41] | CD14-159C/T | 5 | 5 | 11 | 24 | 52 | 26 | 15 | 27 | 100 | 104 |
D’Avila, 2006 [30] | CD14-159C/T | 17 | 24 | 9 | 10 | 11 | 14 | 58 | 42 | 31 | 39 |
Fallavena, 2009 [16] | CD14-159C/T | 59 | 85 | 19 | 98 | 165 | 88 | 203 | 123 | 361 | 341 |